2m 2m 2m 2m 2m 2m 2m
Arbutus Biopharm (ABUS)
NASDAQ
$4.77+$0.11 (+2.34%)
Price as of Jul 14, 2026 4:00 AM EDT- $948.2MMarket Cap
- 43.98%1-Year Change
- BiotechnologyIndustry
Arbutus Biopharm (ABUS)
$4.77+$0.11 (+2.34%)
Earnings Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -5.94% | ||
12-Month Momentum | 29.97% | ||
3-Month Risk Adjusted Momentum | -35.64% | ||
12-Month Risk Adjusted Momentum | 66.88% |
True Yield
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ABUS | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 27 |